125. 神経軸索スフェロイド形成を伴う遺伝性びまん性白質脳症 Disease details / Clinical trials / Drug dev / DR info /

臨床試験数 : 1 / 薬物数 : 9 - (DrugBank : 1) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

CALD HR-D (High-Risk, Regimen C)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
CALD HR-D (High-Risk, Regimen D)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
CALD SR-A (Standard-Risk, Regimen A)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
CALD SR-B (Standard-Risk, Regimen B)
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
IMD Preparative Regimen
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
Osteopetrosis Haploidentical Only Preparative Regimen
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
Osteopetrosis Only Preparative Regimen
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;
Stem Cell Transplantation
   Masonic Cancer Center, University of Minnesota
      2014   Phase 2   NCT02171104   United States;